The 33 references in paper A. Vatazin V., P. Astakhov V., A. Zulkarnaev B., O. Vetchinnikova N., R. Kantaria O., A. Sinutin A., D. Artemov V., А. Ватазин В., П. Астахов В., А. Зулькарнаев Б., О. Ветчинникова Н., Р. Кантария О., А. Синютин А., Д. Артемов В. (2013) “НЕСПЕЦИФИЧЕСКИЕ МЕХАНИЗМЫ ИШЕМИЧЕСКОГО И РЕПЕРФУЗИОННОГО ПОВРЕЖДЕНИЯ ПОЧЕЧНОГО АЛЛОТРАНСПЛАНТАТА И СПОСОБЫ ВОЗДЕЙСТВИЯ НА НИХ // NONSPECIFIC MECHANISMS OF ISCHEMIC AND REPERFUSION INJURY OF RENAL ALLOGRAFT AND ITS MODALITIES” / spz:neicon:nefr:y:2013:i:1:p:42-48

1
Биленко МВ. Ишемические и реперфузионные повреждения органов: молекулярные механизмы, пути предупреждения и лечения. Медицина, М., 1989; 368
(check this in PDF content)
2
Сандриков ВА, Садовников ВИ. Клиническая физиология трансплантированной почки. МАИК «Наука/ Интерпериодикп», М., 2001; 288
(check this in PDF content)
3
Coulson MT, Jablonski P, Howden BO et al. Beyond operational tolerance: effect of ischemic injury on development of chronic damage in renal grafts. Transplantation 2005; 80 (3): 353-361
(check this in PDF content)
4
Veitch PS, Mahendran AO. A total ischemia time of >24 h does not preclude transplantation of kidneys from non-heartbeating donors. Nat Clin Pract Nephrol 2007; 3 (11): 600-601
(check this in PDF content)
5
Salahudeen AK, May W. Reduction in cold ischemia time of renal allografts in the United States over the last decade. Transplant Proc 2008; 40 (5): 1285-1289
(check this in PDF content)
6
Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009; 37 [Suppl 7]: 186-202
(check this in PDF content)
7
Saba H, Munusamy S, Macmillan-Crow LA. Cold preservation mediated renal injury: involvement of mitochondrial oxidative stress. Ren Fail 2008; 30 (2): 125-133
(check this in PDF content)
8
Багненко СФ, Мойсюк ЯГ, Резник ОН. Первый опыт применения аппаратной перфузии почек, полученных от асистолических доноров, для улучшения результатов трансплантации. Вестн трансплантологии и искусственных органов 2006; 8 (3): 9-13
(check this in PDF content)
9
Багненко СФ, Мойсюк ЯГ, Скворцов АЕ, Резник ОН. Реабилитация донорских органов. Направление в консервации или новая парадигма трансплантологии? Вестн трансплантологии и искусственных органов 2009; 11 (3): 17-29
(check this in PDF content)
10
Reznik O, Skvortsov A, Loginov I et al. Kidney from uncontrolled donors after cardiac death with one hour warm ischemic time: resuscitation by extracorporal normothermic abdominal perfusion «in situ» by leukocytes-free oxygenated blood. Clin Transplant 2011; 25 (4): 511-516
(check this in PDF content)
11
Polyak MM, Arrington BO, Stubenbord WT et al. Prostaglandin E1 influences pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys. J Surg Res 1999; 85 (1): 17-25
(check this in PDF content)
12
Ржевская ОН, Тарабарко НВ, Пинчук AB и др. Применение вазапростана в комплексной терапии острого канальцевого некроза после пересадки почки. Вестн трансплантологии и искусственных органов 2006; 8 (5): 21-23
(check this in PDF content)
13
Huang Y, Shan J, Wang C et al. Can ischemic preconditioning alone really protect organs from ischemia reperfusion injury in transplantation. Transpl Immunol 2009; 20 (3): 127-131
(check this in PDF content)
14
O’Brien EA, Bour SA, Marshall RL et al. Effect of use of vasopressors in organ donors on immediate function of renal allografts. J Transpl Coord 1996; 6 (4): 215-216
(check this in PDF content)
15
Brinkkoetter PT, Beck GC, Gottmann U et al. Hypothermiainduced loss of endothelial barrier function is restored after dopamine pretreatment: role of p42/p44 activation. Transplantation 2006; 82(4): 534-542
(check this in PDF content)
16
Ciapetti M, di Valvasone S, di Filippo A et al. Low-dose dopamine in kidney transplantation. Transplant Proc 2009; 41 (10): 4165-4168
(check this in PDF content)
17
Brauer RB, Marx T, Ulm K, Stangl MJ. Effect of perioperative administration of a drug regimen on the primary function of human renal allografts. Transplant Proc 2010; 42 (5): 1523-1525.
(check this in PDF content)
18
Hutchens MP, Dunlap J, HurnPD, Jarnberg PO. Renal ischemia: does sex matter? Anesth. Analg 2008; 107 (1): 239-249
(check this in PDF content)
19
Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59 (4): 565-572
(check this in PDF content)
20
Koo DD, Welsh KI, McLaren AJ et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int 1999; 56 (4): 1551-1559
(check this in PDF content)
21
Schwarz C, Regele H, Steininger R et al. The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation 2001; 71 (11): 1666-1670
(check this in PDF content)
22
Hevesi ZG, Lopukhin SY, Angelini G, Coursin DB. Supportive care after brain death for the donor candidate. Int Anesthesiol Clin 2006; 44 (3): 21-34
(check this in PDF content)
23
Li Z, Nickkholgh A, Yi X et al. Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 2009; 46 (4): 365-372
(check this in PDF content)
24
Nagel E, Meyer zu Vilsendorf A, Bartels M, Pichlmayr R. Antioxidative vitamins in prevention of ischemia/reperfusion injury. Int J Vitam Nutr Res 1997; 67 (5): 298-306
(check this in PDF content)
25
Toledo-Pereyra LH. Organ preservation and ischemic injury. Curr Opin Organ Transplant 2008; 13 (2): 125-128
(check this in PDF content)
26
Yuzer H, Yuzbasioglu MF, Ciralik H et al. Effects of intravenous anesthetics on renal ischemia/reperfusion injury. Ren Fail 2009; 31 (4): 290-296
(check this in PDF content)
27
Garcia-Criado FJ, Lozano-Sanchez F, Fernandez-Regalado J et al. Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. Transplantation 1998; 66 (7): 942-943
(check this in PDF content)
28
Treska V, Molacek J, Kuntscher V et al. Immunosuppresive agents have an influence on ischemia-reperfusion injury in kidneys procured from a non-heart-beating donor: experimental study. Transplant Proc 2004; 36 (10): 2931-2934
(check this in PDF content)
29
Hauet T, Goujon JM, Vandewalle A. To what extent can limiting cold ischaemia/reperfusion injury prevent delayed graft function? Nephrol Dial Transplant 2001; 16 (10): 1982-1985
(check this in PDF content)
30
Damman J, Daha MR, van Son WJ et al. Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant 2011; 11 (4): 660-669
(check this in PDF content)
31
Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364 (9447): 1814-1827
(check this in PDF content)
32
Zaouali MA, Ben Abdennebi H, Padrissa-Altés S et al. Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin Pharmacother 2010; 11 (4): 537-555
(check this in PDF content)
33
Горяйнов ВА, Каабак ММ, Молчанова ЕА. Плазмаферез для лечения реперфузионной травмы при пересадке почки – влияние на ближайший и отдаленный результат. Вестн РАМН 2002; (5): 43-45 Поступила в редакцию 27.06.2012 г.
(check this in PDF content)